Dr. Francesca Ferraro joined the Department of Medicine in the Division of Oncology as an Instructor in July, 2018. She was a resident at Pennsylvania Hospital in Philadelphia before becoming a Hematology Oncology fellow at Washington University in 2016, and ultimately an Instructor.
Dr. Ferraro’s research interest is studying acute myeloid leukemia (AML). In recent years, sequencing techniques have accelerated our discovery of the mutational events that contribute to the establishment and progression of AML and have highlighted the role of dysfunctional epigenetic regulators in the pathogenesis of this disease. In contrast to genetic mutations, which are considered permanent events, epigenetic changes have the potential to be restored, and this makes them attractive clinical targets. Her main project focuses on understanding and improving the efficacy of epigenetic therapies in AML.